Cancer BiologybioRxiv
CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells
A. Conery, A. Bommi-Reddy, S. Park-Chouinard…·R. J. Sims
This study shows that inhibiting CREBBP/EP300 acetyltransferase suppresses ER+ breast cancer growth by disrupting FOXA1-bound enhancers, offering a new therapeutic strategy.
DOI 10.1371/journal.pone.0262378